• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTERNATIONAL TECHNIDYNE CORP. HEMOCHRON JR. CITRATE APTT CUVETTE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTERNATIONAL TECHNIDYNE CORP. HEMOCHRON JR. CITRATE APTT CUVETTE Back to Search Results
Catalog Number J103C
Device Problems Nonstandard Device (1420); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Abdominal Pain (1685)
Event Date 11/11/2013
Event Type  malfunction  
Event Description
Healthcare professional reports results higher than reference laboratory with hemochron jr.Citrated aptt cuvette assay for pt with admitting diagnosis of abdominal pain and cholecystitis.Hemochron jr.Citrated aptt test generated result of 113 seconds, which was higher than the physician's expectations.Sample tested at the reference laboratory and result was 47.5 seconds.Pt management was based on the laboratory result.No adverse event(s) reported.
 
Manufacturer Narrative
(b)(4).Method: cuvette/single-use disposable.As part of itc's investigation, evaluation testing was performed on retain samples of a similar lot.Process evaluation performed.Review and trend analysis of finished product qc test data was performed.Manufacturing process reviewed.Result: an upward shift in non-heparinized blood response when compared to historical performance was identified.Conclusion: manufacturer notified fda on december 6, 2013 of the voluntary recall of (b)(4) lots of hemochron jr.Citrate aptt cuvettes.Itc's investigation into the product's performance identified that the affected lots of j103c cuvettes may recover higher than expected results in normal individuals.When testing non-heparinized (e.G.Normal blood samples), results may average higher than historic values.Test results performed on patients receiving heparin therapy are not affected.The upward shift in non-heparinized blood response is associated with a recent formulary optimization.Correction of the normal range shift being implemented to assure that test results from non-heparinized sampled in future lot releases will perform similar to historic experiences.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOCHRON JR. CITRATE APTT CUVETTE
Manufacturer (Section D)
INTERNATIONAL TECHNIDYNE CORP.
edison NJ 08820
Manufacturer Contact
eleanor fox
20 corporate place south
piscataway, NJ 08854
7325485700
MDR Report Key3787201
MDR Text Key4432952
Report Number2248721-2014-00004
Device Sequence Number1
Product Code GFO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K014008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial
Report Date 01/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2014
Device Catalogue NumberJ103C
Device Lot NumberE3JCC014-P2
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number2250033-12/06/13-002
Patient Sequence Number1
Patient Age69 YR
-
-